Sree Rayalaseema Hi-Strength Q1 Results: Net profit up 7.6% YoY to ₹251.8 crore

1 min read     Updated on 13 Aug 2026, 01:36 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Sree Rayalaseema Hi-Strength Hypo Ltd posted Q1FY27 standalone net profit of ₹251.8 crore, up 7.6% YoY, on a 15.8% revenue jump to ₹2,208.3 crore. Consolidated PAT rose to ₹247.4 crore. The results were approved by the board on August 12, 2026.

powered bylight_fuzz_icon
48153982

*this image is generated using AI for illustrative purposes only.

Sree Rayalaseema Hi-Strength Hypo Limited reported a standalone net profit of ₹251.8 crore for the quarter ended June 30, 2026, marking a 7.6% increase from ₹234.1 crore in the same period last year. Revenue from operations rose 15.8% year-on-year to ₹2,208.3 crore, up from ₹1,906.6 crore in Q1FY26.

The company’s board of directors approved the unaudited financial results in a meeting held on August 12, 2026. The figures were reviewed by the Audit Committee and published in Business Standard and Andhra Prabha on August 13, 2026, in compliance with Regulation 47(1)(b) of the SEBI (LODR) Regulations, 2015.

Financial Highlights

Metric: Q1FY27 Q1FY26 Change (YoY)
Revenue from Operations: ₹2,208.3 crore ₹1,906.6 crore +15.8%
Net Profit (After Tax): ₹251.8 crore ₹234.1 crore +7.6%
EPS (Basic): ₹14.67 ₹13.64 +7.6%

On a consolidated basis, net profit after tax stood at ₹247.4 crore, compared to ₹224.1 crore in the corresponding quarter of the previous fiscal. Consolidated revenue remained nearly flat at ₹2,208.1 crore against ₹1,906.4 crore in Q1FY26.

What the Numbers Show

The divergence between top-line growth and bottom-line expansion indicates margin compression during the quarter. While revenue grew by nearly 16%, net profit expanded by less than 8%, suggesting that cost structures or input prices may have risen faster than sales realization. This is further evidenced by the pre-tax profit growth of 6.6% (₹343.5 crore vs ₹323.2 crore), which trails the revenue growth rate significantly.

Earnings per share (basic) increased to ₹14.67 from ₹13.64 in the prior year period. The total comprehensive income for the quarter was ₹638.1 crore, a sharp reversal from the negative comprehensive income of ₹(377.7) crore recorded in the preceding quarter (Q4FY26), indicating a normalization in other comprehensive income items such as foreign currency translation differences or revaluation reserves.

Historical Stock Returns for Sree Rayalaseema Hi-Strength Hypo

1 Day5 Days1 Month6 Months1 Year5 Years
+0.50%-3.14%+0.21%+1.40%-19.47%+50.42%

What specific cost drivers or input price increases contributed to the margin compression despite the 15.8% revenue growth?

How does management plan to address the divergence between top-line expansion and bottom-line profitability in upcoming quarters?

Will the company declare a dividend for Q1FY27, and how might this impact cash flow given the margin pressures?

Sree Rayalaseema Hi-Strength Hypo
View Company Insights
View All News
like19
dislike

Sree Rayalaseema profit up 7.5% in Q1FY26 as EBITDA margin slips

3 min read     Updated on 13 Aug 2026, 01:26 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Sree Rayalaseema Hi-Strength Hypo Limited posted a 7.5% rise in Q1FY26 standalone net profit to ₹251.7 crore, aided by a 17% revenue jump to ₹2,109.5 crore. EBITDA reached ₹299 crore but margins slipped to 14.16% from 15.81% YoY due to higher material costs. The company also announced its AGM for September 26, 2026, and appointed Phaneendra Rao Kasturi as an additional independent director.

powered bylight_fuzz_icon
48075539

*this image is generated using AI for illustrative purposes only.

Sree Rayalaseema Hi-Strength Hypo Limited reported a 7.5% increase in standalone net profit to ₹251.7 crore for the first quarter of FY26, driven by a 17% surge in revenue from operations to ₹2,109.5 crore. Despite the top-line growth, the company’s EBITDA margin contracted to 14.16% from 15.81% in Q1FY25, with EBITDA rising modestly to ₹299 million (₹299 crore) from ₹285 million (₹285 crore) year-on-year.

The Board of Directors approved the unaudited financial results on August 12, 2026, in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. S.T. Mohite & Co., Chartered Accountants, issued a limited review report confirming that the statements comply with Indian Accounting Standards (Ind AS). The company continues to report only one operating segment—Chemicals—as wind energy power contributes less than 10% of total revenue.

Financial Performance Highlights

Metric Standalone Q1FY26 Standalone Q1FY25 Change
Revenue from Operations (₹ Cr) 2,109.46 1,802.55 +17.0%
EBITDA (₹ Cr) 299.00 285.00 +4.9%
EBITDA Margin (%) 14.16 15.81 -165 bps
Net Profit After Tax (₹ Cr) 251.72 234.10 +7.5%
Earnings Per Share (₹) 14.66 13.64 +7.5%

Standalone earnings per share stood at ₹14.66, up from ₹13.64 in the corresponding quarter of FY25. Consolidated net profit rose 10.3% to ₹247.3 crore from ₹224.15 crore. The profit growth was supported by a reduction in exceptional items, which included a net loss of ₹35.0 crore from gold futures fair valuation at mark-to-market prices. This loss was partially offset by profits from other gold future contracts during the quarter.

Corporate Governance Updates

The Board appointed Phaneendra Rao Kasturi as an Additional Director in the capacity of Non-Executive Independent Director for a term of five years, effective August 12, 2026. His appointment is subject to regularization by shareholders at the ensuing AGM. Kasturi, a Fellow Chartered Accountant with over two decades of experience, was also inducted into the Audit Committee, Nomination & Remuneration Committee, Stakeholders Relationship Committee, Corporate Social Responsibility Committee, and Risk Management Committee.

The AGM is scheduled for September 26, 2026, at 4 P.M. via Video Conference/OVAM. The record date for dividend payment and e-voting is September 18, 2026. E-voting through the CDSL platform begins on September 23, 2026, at 9:00 A.M. and ends on September 25, 2026, at 5:00 P.M. MNM & Associates has been appointed as scrutinizers for the voting process. Dividend payments are expected on or before October 23, 2026.

What the Numbers Show

The divergence between revenue growth (17%) and net profit growth (7.5%) indicates margin pressure, likely stemming from higher cost of materials consumed, which rose to ₹1,139.9 crore from ₹983.7 crore in Q1FY25. The contraction in EBITDA margin to 14.16% from 15.81% further underscores this cost inflation, as EBITDA grew only 4.9% despite robust top-line expansion. However, the company managed to control employee benefits and finance costs, keeping them relatively stable. The significant rise in other comprehensive income, driven by a ₹516.4 crore gain on FVTOCI financial instruments, boosted total comprehensive income to ₹638.1 crore, highlighting the impact of investment performance on overall equity value.

Legal Proceedings Update

Sree Rayalaseema continues to face legal proceedings initiated by Maersk Shipping Line in the Business and Property Courts of England and Wales. The claimant seeks damages of USD 13,178,280.51 for alleged breaches of contract of carriage. The company disputes the claim and has secured interim reliefs from Indian courts, including an order restraining Maersk from pursuing foreign proceedings under the Hague Convention. Management stated that the ultimate financial liability remains undetermined as appropriate legal remedies are being pursued.

Historical Stock Returns for Sree Rayalaseema Hi-Strength Hypo

1 Day5 Days1 Month6 Months1 Year5 Years
+0.50%-3.14%+0.21%+1.40%-19.47%+50.42%

How will the company mitigate the rising cost of materials to prevent further EBITDA margin contraction in upcoming quarters?

What is the expected timeline and potential financial impact of the ongoing legal dispute with Maersk Shipping Line on future cash flows?

Will the appointment of Phaneendra Rao Kasturi influence any strategic shifts in risk management or corporate governance practices?

Sree Rayalaseema Hi-Strength Hypo
View Company Insights
View All News
like18
dislike

More News on Sree Rayalaseema Hi-Strength Hypo

1 Year Returns:-19.47%